Immunogenicity and Safety of GSK Biologicals' IPV (Poliorix™) in Infants
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00000874/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of the study is to evaluate the immunogenicity and safety of Poliorix™ when administered to healthy Chinese infants at 2, 3 and 4 months of age.
提供机构：
Vivli
创建时间：
2018-10-27
